Sabra Healthcare Price To Earning vs. Operating Margin
| SBRA Stock | USD 16.92 0.18 1.05% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.39 | 0.4157 |
|
| |||||
| Operating Profit Margin | 0.47 | 0.3421 |
|
|
For Sabra Healthcare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sabra Healthcare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sabra Healthcare REIT utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sabra Healthcare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sabra Healthcare REIT over time as well as its relative position and ranking within its peers.
Sabra |
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.111 | Dividend Share 1.2 | Earnings Share 0.41 | Revenue Per Share 2.943 | Quarterly Revenue Growth 0.107 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sabra Healthcare REIT Operating Margin vs. Price To Earning Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sabra Healthcare's current stock value. Our valuation model uses many indicators to compare Sabra Healthcare value to that of its competitors to determine the firm's financial worth. Sabra Healthcare REIT is rated second in price to earning category among its peers. It is rated fourth in operating margin category among its peers reporting about 0.01 of Operating Margin per Price To Earning. The ratio of Price To Earning to Operating Margin for Sabra Healthcare REIT is roughly 185.49 . At present, Sabra Healthcare's Operating Profit Margin is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sabra Healthcare's earnings, one of the primary drivers of an investment's value.Sabra Operating Margin vs. Price To Earning
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Sabra Healthcare |
| = | 67.37 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Sabra Healthcare |
| = | 0.36 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Sabra Operating Margin Comparison
Sabra Healthcare is currently under evaluation in operating margin category among its peers.
Sabra Healthcare Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sabra Healthcare, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sabra Healthcare will eventually generate negative long term returns. The profitability progress is the general direction of Sabra Healthcare's change in net profit over the period of time. It can combine multiple indicators of Sabra Healthcare, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 23.7 M | 24.9 M | |
| Operating Income | 221.5 M | 163.2 M | |
| Income Before Tax | 15.8 M | 15 M | |
| Net Income | 13.8 M | 13.1 M | |
| Income Tax Expense | 2 M | 1.9 M | |
| Total Other Income Expense Net | -205.8 M | -195.5 M | |
| Net Loss | -69.8 M | -66.4 M | |
| Net Income From Continuing Ops | 13.8 M | 13.1 M | |
| Non Operating Income Net Other | -12.2 M | -11.6 M | |
| Net Interest Income | -113 M | -118.6 M | |
| Interest Income | 7.8 M | 6.7 M | |
| Change To Netincome | 243.8 M | 256 M | |
| Net Income Per Share | 0.06 | 0.06 | |
| Income Quality | 21.85 | 22.94 | |
| Net Income Per E B T | 0.87 | 0.83 |
Sabra Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sabra Healthcare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sabra Healthcare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sabra Healthcare's important profitability drivers and their relationship over time.
Use Sabra Healthcare in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sabra Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sabra Healthcare will appreciate offsetting losses from the drop in the long position's value.Sabra Healthcare Pair Trading
Sabra Healthcare REIT Pair Trading Analysis
The ability to find closely correlated positions to Sabra Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sabra Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sabra Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sabra Healthcare REIT to buy it.
The correlation of Sabra Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sabra Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sabra Healthcare REIT moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sabra Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sabra Healthcare position
In addition to having Sabra Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Cap ETFs Thematic Idea Now
Large Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large Cap ETFs theme has 686 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
To fully project Sabra Healthcare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sabra Healthcare REIT at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sabra Healthcare's income statement, its balance sheet, and the statement of cash flows.